
I Spent More Than a Month on the Anthros V2. Here's Why This Office Chair Rules
Anthros is a newcomer to the scene, only launching the first version of the chair in 2023. It makes grand claims about improving your posture and offering better support than office stalwarts like Herman Miller. It doesn't help that the V2 chair is north of $2,000, though it seems to be on sale often enough for around $1,900.
But after nearly two months of sitting, the claims hold up—I find it more supportive than almost all the chairs I've tested, and my posture has been great. The Embody still holds a place in my heart, but the Anthros V2 might be the best chair for anyone looking to sharpen up their posture, especially if you've been dealing with back pain. Pelvic Support
Photograph: Julian Chokkattu
The Anthros chair focuses on supporting the pelvis, not the lumbar, similar to Herman Miller's Aeron and Embody, except it gives you far more to work with when dialing in the backrest. After setting it up, I had a call with an Anthros ergonomics therapist, something that's included for every customer. The therapist looks at how you're sitting in the chair (via video call) and will make suggestions until you feel comfortable in the seat. I wish every luxe chair offered such a service.
The rear knobs on the left and right of the chair control the two-part backrest system. The right knob moves the lumbar backrest forward and back, and the left knob handles the top. I haven't sat on a chair that lets you adjust the backrest to this degree, and I find it helps tailor the chair precisely to your body shape. It's the top backrest that took me a little time to get used to.
On my first day in the chair, I felt a little sore because it almost felt like the chair was pushing in. In reality, there wasn't any pressure, and I started feeling my back gently resting on the backrest. It was my posture correcting itself; it felt straight as a whistle. I also appreciate the compact design, which proves that you don't need your whole back to be held up by a backrest to feel supported, much like how you don't need a headrest on an office chair if it's designed well.
I spent a lot of time reclining in this chair, and my posture didn't change. You can lock the recline with the front left knob, but I kept it unlocked on the tightest tension (via the front right knob), allowing me to gently slope back. I never felt uncomfortable. That might also be due to the plush Cloudfloat seat, which is thicker than what you'll find on most high-end office chairs.
My only gripe with this seat is that I found the depth lacking for my 6'4" frame. It leaves about six fingers' worth of a gap between the edge and the back of my knee, when it should ideally be two to three. It's not a deal-breaker, but I'd have liked to feel that coverage extend closer to my knee. The seat is the perfect width for me, though taller and bigger folks may find it constricting. Got Your Back
Photograph: Julian Chokkattu
There's a good degree of customization when purchasing the chair. You can choose between a white or black frame, add fun back panels like wood or specific designs, and opt for fabric or leather upholstery. I've been sitting on the smooth Athlon Performance fabric, which hasn't shown any signs of pilling even after nearly two months of daily use.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
Dionysus Health and Mammha Announce Groundbreaking Partnership to Transform Postpartum Depression Care Through Precision Diagnostics and Comprehensive Support
SAN DIEGO, CA - July 30, 2025 (NEWMEDIAWIRE) - Dionysus Health, the molecular diagnostics company behind myLuma(TM), and Mammha, a leading provider of accessible, full-spectrum perinatal mental health care, today announced a groundbreaking partnership to fundamentally reshape how postpartum depression (PPD) is predicted, prevented, and treated. This first-of-its-kind collaboration combines myLuma(TM) - the first predictive prenatal blood test for postpartum depression risk - with Mammha's clinician-designed care platform, delivering the most complete and proactive maternal mental health solution on the market. myLuma(TM) is the first clinically validated molecular diagnostic that predicts a woman's risk of PPD with 85% accuracy from a simple third-trimester blood draw. This allows providers to intervene as early as 28 weeks into pregnancy - weeks to months before symptoms may appear. Combined with Mammha's full continuum of care, the partnership ensures mothers are not only identified early but supported throughout their entire maternal journey. "This partnership brings together scientific innovation and clinical care to deliver a true end-to-end solution," said Dr. Andrea Cubitt, CEO of Dionysus Health. "myLuma(TM) provides the critical early warning system through molecular diagnostics, while Mammha ensures timely care delivery. We're moving from reactive treatment to proactive prevention, from uncertainty to precision, and from fragmented efforts to coordinated care." "We created Mammha to fill the gaps in the perinatal healthcare system that parents have been falling through for much too long," said Maureen Fura, CEO of Mammha. "Partnering with Dionysus Health gives us the predictive power we've always dreamed of having, so that we can intervene early and effectively." Why This Matters Now Postpartum depression is one of the most urgent and preventable maternal health crises: PPD contributes to almost 1 in 4 maternal deaths 75% of affected women receive no treatment The U.S. spends over $17 billion annually addressing the consequences 96% of U.S. counties face mental health provider shortages Only 33% of providers screen for perinatal depression (HEDIS) "We're solving for OB providers, health systems, and mothers," said Alisa Marie Beyer, COO of Dionysus Health. "While screening tools remain essential for identifying current symptoms, until now there's been no biological diagnostic for PPD to predict risk before symptoms emerge. This partnership brings predictive data and enhanced support tools to enable proactive prevention, earlier intervention, and better outcomes for everyone involved." Next Steps for Launch and Growth The integrated myLuma solution is projected to kick-off in September 2025 with a pilot program involving multiple OB providers across California and Florida, aiming for 100 completed patient tests per month. It is anticipated to grow the pilot to an additional 50 OB providers. The full-scale launch is planned for January 2026, targeting 100 provider offices and serving over 1,000 women monthly. Dionysus Health is currently managing a growing waitlist of providers and patients ahead of the national rollout. About Dionysus Health is a molecular diagnostics company focused on maternal mental health breakthroughs. The company developed MyLuma(TM), the first prenatal blood test that predicts postpartum depression risk with 85% accuracy, enabling personalized treatment and support for every mother. Dionysus Health's mission is to replace delayed, self-reported screenings with clinically validated diagnostics that deliver reliable, early insights for patients, providers, and health systems. Mahmma is on a mission to provide a comprehensive, accessible perinatal mental health solution. Created by clinicians and parents, Mahmma serves as the go-to solution for providers, health systems, hospitals, and NICUs to screen, refer, support, educate, and treat pregnant and postpartum women experiencing maternal mental health complications like depression and anxiety, and their families. Media Contact Full Name: Amy VanHaren Company Name: Dionysus Health Email: avanharen@ Phone Number: 6513038777 Website: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


CBS News
14 minutes ago
- CBS News
Lawsuit alleges Hormel Foods denied workers earned safe and sick time
Workers are suing Minnesota-based Hormel Foods, alleging the food giant does not allow employees to take paid time off if they get sick. The class action lawsuit alleges Hormel violated the Minnesota Earned Safe and Sick Time law for UFCW Local 663 members. The union represents more than 1,600 meatpacking workers at Hormel's Austin, Minnesota, plant. The lawsuit claims workers had to use vacation days instead of sick days if they wanted to get paid for the time off. Hormel is accused of refusing to provide employees with earned sick and safe time (ESST) benefit accruals for their work between Jan. 1, 2024, and March 1, 2025, and denying the workers' statutory right to carry over their accrued, unused ESST benefits into the 2025 calendar year. The lawsuit also alleges Hormel failed to give "all or most" employees any of the ESST benefits they earned in January and February this year, "Workers, advocates, and legislators fought hard to make Earned Sick and Safe Time law. Now, ESST is a statewide standard," said UFCW Local 663 President Rena Wong. "UFCW 663 members know what it means to fight for what we deserve and win. After all, workers at Hormel set the standard for wages in the meatpacking industry." Hormel declined to comment. The lawsuit is the first of its kind since the law passed in 2023, according to the Minnesota Senate DFL. Under the law, anyone is eligible for the sick and safe time if they work 80 hours a year and don't qualify as an independent contractor. The policy approved by the DFL-led legislature allows people to use the time for treating mental or physical illness, going to medical appointments, caring for a family member who's ill, and even due to inclement weather that may close children's school and keep them home. It also covers absences related to domestic abuse or sexual assault. "As chief author of the 2023 Earned Sick and Safe Time law, I am proud to stand with the workers of UFCW Local 663 as they demand the rights they are due," Sen. Sandra Pappas, DFL-St. Paul, said. "Hormel must follow Minnesota law and stop disrespecting its workers. I look forward to UFCW Local 663's day in court." There's a long history of labor activism at the Hormel plant in Austin. In the mid-1980s, about 1,500 workers went on strike for 13 months in one of the longest strikes in state history. The employees cited a wage freeze, dangerous working conditions and a wage cut as the reason for the Cummings contributed to this report.


New York Times
44 minutes ago
- New York Times
Trump Announces Health Care Records System for Consumers
President Trump on Wednesday announced the development of a health care records system that he said would allow Americans to more easily and broadly share their personal health information with health care providers. 'Today the dream of easily transportable, electronic medical records finally becomes a reality,' Mr. Trump said at a White House event that included the leaders of dozens of technology companies. The administration is working with some of the largest American companies on the record-keeping system, including Google, Amazon, Apple and OpenAI. The Centers for Medicare and Medicaid Services will oversee the effort. Many health care providers already allow patients to upload their medical information and schedule appointments through phone apps and online portals. Mr. Trump and top federal health officials said the information-sharing program would be an effective replacement for a system that often involves arduous and redundant paperwork that patients fill out when visiting different providers. The system, which aims in part to help Americans with diabetes and obesity, would also include artificial intelligence assistants to help Americans monitor symptoms and navigate health care options. Want all of The Times? Subscribe.